The survey, unveiled ahead of next week's CPhI Festival of Pharma, reveals perspectives, concerns and future plans of more than 500 industry executives.
DNAnexus has secured $58m financing, including a strategic investment from Microsoft, in order to further develop its translational medicine solutions.
EyeCRO and MPI Research are co-developing large mammalian preclinical models for ophthalmic diseases as clients look to perform pharmacology studies in larger species.
Industry headhunters have picked their top CEOs in European pharma, saying the most successful investors keep chief execs in place even through hard times.
Changes at PTI, a new CEO at CROS and SCM Pharma’s US expansion head up the executive changes in this week’s Outsourcing-pharma.com’s People on the Move column.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, in a rather global edition including news from Israel, Bangladesh and Australia.
in-PharmaTechnologist.com presents its weekly round-up of the latest movers and shakers in the world of pharmaceuticals, including news from Daiichi Sankyo, Galenea and Lannett.
Dyax announced that it has reached a mutual agreement with Genzyme
to terminate their joint venture for the development and
commercialization of DX-88 for hereditary angioedema (HAE).
Alcan has acquired the outstanding minority share of Propack in a
deal that further cements the company's standing in the Chinese
market. The acquisition forms part of a major restructuring
exercise, in which the closure and...
Ireland's Elan has signed its first major contract manufacturing
and supply agreement in a development that reinforces its
credentials as a player in the outsourcing sector.
UK microbial testing company Celsis International announced this
week that food giant Nestle has selected Celsis' recently launched
milk and cream diagnostic system for its global Research &
Development site in Konolfingen.
